Aryl hydrocarbon receptor modulator
AssigneeAriagen, Inc.
InventorsJiasheng Song, Suoming Zhang, Guodong Li, Luqing Yang
Life of this patent
Estimating the term…
Loading patent…
AssigneeAriagen, Inc.
InventorsJiasheng Song, Suoming Zhang, Guodong Li, Luqing Yang
Estimating the term…
Disclosed is an aryl hydrocarbon receptor modulator of formula (I), and a pharmaceutically acceptable salt thereof, wherein R′ is H, CN, CH2(OH)R0, CmH2m+1, CnH2n−1, CnH2n−3, two Ra are independently H or two Ra together form =0 or ═N—W3—R1; A is a C6 to C10 aromatic ring unsubstituted or substituted with 1 to 3 R, or a C2-C10 heteroaromatic ring interrupted by 1 to 5 heteroatoms selected from N, 0, and S or a 4 to 7 membered nonaromatic heterocyclic ring containing C═N and interrupted by 1 to 3 heteroatoms selected from N, 0, and S, with either one unsubstituted or substituted with 1 to 3 R; Q is R, or is a C6 to C10 aromatic ring or a C2 to C10 heteroaromatic ring unsubstituted or substituted with 1 to 3 R and interrupted by 1 to 5 heteroatoms selected from N, 0, and S; and R is RC which is C-attached or RN which is N-attached. The compounds of formula (I) of the present invention can regulate AhR activity, and can be used to inhibit the growth of cancer cells and inhibit the metastasis and invasion of tumor cells.
An aryl hydrocarbon receptor modulator of formula (I), and a pharmaceutically acceptable salt thereof,
20-29. (canceled)
Dependencies are inferred from the claim text.